Remote Management of Pacemakers and Implantable Defibrillators – Role and Long-term Viability
4. Heidbuchel H, Lioen P, Foulon S, et al., Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator, Europace, 2008;10:351–7.
5. Varma N, Epstein AE, Irimpen A, et al., Efficacy and safety of automatic remote monitoring for implantable cardioverter- defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial, Circulation, 2010;122:325–32.
6. Mabo P, Victor F, Bazin P, et al., A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial), Eur Heart J, 2011, 29 November [Epub ahead of print].
7. Crossley GH, Boyle A, Vitense H, et al., The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts, J Am Coll Cardiol, 2011;57:1181–9.
8. Kacet S, ECOST: Safety of Implantable Cardioverter
Defibrillator Follow-up Using Remote Monitoring: A Randomized Controlled Trial, Presented at: European Society of Cardiology Annual Scientific Sessions, Paris, France, 29 August, 2011.
9. Saxon LA, Hayes DL, Gilliam FR, et al., Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study, Circulation, 2010;122:2359–67.
10. Burri H, Quesada A, Ricci RP, et al., The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE- CARE) study: rationale and design, Am Heart J, 2010;160:42–8.
11. Ip J, Waldo AL, Lip GY, et al., Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort. The IMPACT study, Am Heart J, 2009;158:364–70.
12. Ricci RP, Morichelli L, Quarta L, et al., Long-term patient acceptance of and satisfaction with implanted device
remote monitoring, Europace, 2010;12:674–9.
13. Ricci RP, Morichelli L, Santini M, Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization, Europace, 2008;10:164–70.
14. Burri H, Heidbüchel H, Jung W, et al., Remote monitoring: a cost or an investment?, Europace, 2011;13:ii44–ii8.
15. Boriani G, Burri H, Mantovani LG, et al., Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario, Europace, 2011;13:ii59–ii65.
16. Medtronic, Clinician Manual Supplement Protecta™ XT/Protecta™, 489 Projected Service Life Information Related to Remote Monitoring, Manual No. M945739A001A, Minneapolis 490: Medtronic Inc., 2010.
17. Hayes DL, Boehmer JP, Day JD, et al., Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival, Heart Rhythm, 2011;8:1469–75.
EUROPEAN CARDIOLOGY
97
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76